Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers

计划入组 26 人 · 首次发布于 2019 年 2 月 8 日

Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions

计划入组 30 人 · 首次发布于 2025 年 1 月 30 日

The Effect of Endogenous GLP-1 on Glucagon Secretion in Type 1 Diabetes

计划入组 12 人 · 首次发布于 2026 年 1 月 28 日

GIP/GLP-1/Glucagon mono/dual/triple therapeutic

ZP-GG-72

Retatrutide

Alturas Minerals Corp

United States

NHI-1

United States

Xi'an No.1 Hospital

China

OPKO Health and Entera Bio Collaborate to Develop First Oral GLP-1/Glucagon Dual Agonist for Obesity Treatment

OPKO Health and Entera Bio Advance First-in-Class Oral Dual GLP-1/Glucagon Tablet for Obesity Treatment

D&D Pharmatech Completes Enrollment for Phase 2 MASH Trial of Novel Dual GLP-1/Glucagon Agonist DD01